ECTRIMS-ACTRIMS 2023: Disease-Modifying Therapies for Multiple Sclerosis Improve Cognition and Fine Motor Function
Women and less educated patients less likely to use disease-modifying therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.